FDA Recalls Nephron Cardioplegia Solution Over Sterility Assurance Concerns
Nephron Sterile Compounding Center is recalling del Nido Cardioplegia Solution due to lack of assurance of sterility. The 1765 bags affected were distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves a medical product with critical sterility concerns for use in cardiac surgery. The hazard of lack of sterility assurance poses significant risk, though no contamination or adverse events have been reported.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling 1765 bags of del Nido Cardioplegia Solution due to lack of assurance of sterility. This solution is a sterile injectable medication used during cardiac surgical procedures.
The affected lots are: NC2031A (expires 7/7/2022), NC2033A (expires 7/12/2022), NC2034A (expires 7/18/2022), and NC2035A (expires 7/19/2022). The product was distributed nationwide in the United States.
Healthcare facilities that may have received this product should verify their inventory against the lot numbers listed above to determine if they have any affected items.
The recalled product
- Product
- del Nido Cardioplegia Solution 1000 mL (1000 mL) Single-Dose Container IV bag, 4 x 1 IV Bag per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-984-10
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Hazard
- sterility-assurance
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lots: NC2031A
- Exp. 7/7/2022
- NC2033A
- Exp. 7/12/2022
- NC2034A
- Exp. 7/18/2022
- NC2035A
- Exp. 7/19/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27